Regulation of cyclooxygenase-2 pathway by HER2 receptor

Emerging lines of evidence suggest that in addition to growth factors, the process of colorectal tumorigenesis map also be driven by the upregulation of the inducible form of cyclooxygenase-2 (COX-2), an enzyme responsible for the conversion of arachidonic acid to PGEs, The present study was undertaken to investigate the expression and activation of the HER family members, and to explore the regulation of COS-2 expression by the HER2 pathway in human colorectal cancer cells. Here, rye report that human colorectal cancer cell lines express abundant levels of HER2, and HER3 receptors, and are growth-stimulated by recombinant neu-differentiation factor-beta 1 (NDF), NDF-treatment of colorectal cancer cells was accompanied by increased tyrosine phosphorylation and heterodimerization of HER3 with HER2, In addition, we demonstrated that HER2 and HER3 receptors in colorectal cancer cells are constitutively phosphorylated on tyrosine residues and form heterodimeric complexes in the absence of exogenous NDF, Inhibition of HER2/HER3 signaling by an anti-HER3 mAb against the ligand binding site resulted in a decrease in the levels of constitutively activated HER2/HER3 heterodimers, and the unexpected reduction of COS-2 expression, Activation of the HER2/HER3 pathway by NDF induced the activation of COX-2 promoter, expression of COX-2 mRNA, COX-2 protein and accumulation of prostaglandin E2 in the culture medium. Finally, we demonstrated that NDF promotes the ability of colorectal cancer cells to sur,ive in an extracellular matrix milieu, such as Matrigel, and also to invade through a 8 mu m porous membrane. These biological activities of NDF and its stimulation of cell proliferation are blocked by a specific inhibitor of COX-2, Taken together, our findings provide the first biochemical evidence of a possible role of the COS-2 pathway in the mitogenic action of NDF in colorectal cancer cells where it may be constitutively upregulated due to the autocrine/paracrine activation of HER2/HER3 heterodimers.